MedPath
TGA Approval

BIRESP SPIROMAX budesonide / formoterol (eformoterol) fumarate dihydrate 400 microgram /12 microgram powder for inhalation dry powder inhaler (267384)

267384

BIRESP SPIROMAX budesonide / formoterol (eformoterol) fumarate dihydrate 400 microgram /12 microgram powder for inhalation dry powder inhaler

Teva Pharma Australia Pty Ltd

December 19, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/14533f583754a0c457d23c26ff16f146.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/ba4adf1660c8a864552ce0c3b3f8d971.pdf

Active Ingredients

budesonide

formoterol fumarate dihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIRESP SPIROMAX budesonide / formoterol (eformoterol) fumarate dihydrate 400 microgram /12 microgram powder for inhalation dry powder inhaler (267384) - TGA 批准文号 | MedPath